1. Home
  2. ABEO vs MEC Comparison

ABEO vs MEC Comparison

Compare ABEO & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • MEC
  • Stock Information
  • Founded
  • ABEO 1974
  • MEC 1945
  • Country
  • ABEO United States
  • MEC United States
  • Employees
  • ABEO N/A
  • MEC N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • MEC Industrial Specialties
  • Sector
  • ABEO Health Care
  • MEC Industrials
  • Exchange
  • ABEO Nasdaq
  • MEC Nasdaq
  • Market Cap
  • ABEO 256.9M
  • MEC 249.1M
  • IPO Year
  • ABEO 1980
  • MEC 2019
  • Fundamental
  • Price
  • ABEO $6.24
  • MEC $15.76
  • Analyst Decision
  • ABEO Strong Buy
  • MEC Buy
  • Analyst Count
  • ABEO 5
  • MEC 2
  • Target Price
  • ABEO $17.80
  • MEC $18.00
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • MEC 115.8K
  • Earning Date
  • ABEO 05-15-2025
  • MEC 05-06-2025
  • Dividend Yield
  • ABEO N/A
  • MEC N/A
  • EPS Growth
  • ABEO N/A
  • MEC 160.08
  • EPS
  • ABEO N/A
  • MEC 1.08
  • Revenue
  • ABEO N/A
  • MEC $555,914,000.00
  • Revenue This Year
  • ABEO N/A
  • MEC N/A
  • Revenue Next Year
  • ABEO $383.07
  • MEC $9.90
  • P/E Ratio
  • ABEO N/A
  • MEC $14.56
  • Revenue Growth
  • ABEO N/A
  • MEC N/A
  • 52 Week Low
  • ABEO $3.93
  • MEC $11.72
  • 52 Week High
  • ABEO $7.32
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • MEC 63.29
  • Support Level
  • ABEO $5.93
  • MEC $15.60
  • Resistance Level
  • ABEO $7.17
  • MEC $16.15
  • Average True Range (ATR)
  • ABEO 0.44
  • MEC 0.52
  • MACD
  • ABEO -0.01
  • MEC 0.04
  • Stochastic Oscillator
  • ABEO 50.00
  • MEC 72.24

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: